dehydroepiandrosterone sulfate has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterjee, R; Kottaridis, PD; Linch, DC; McGarrigle, HH | 1 |
1 other study(ies) available for dehydroepiandrosterone sulfate and Hematologic Malignancies
| Article | Year |
|---|---|
Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Erectile Dysfunction; Follicle Stimulating Hormone; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hormone Replacement Therapy; Humans; Injections, Intramuscular; Leydig Cells; Libido; Luteinizing Hormone; Male; Penile Erection; Penis; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Transplantation Conditioning; Ultrasonography; Vasodilator Agents | 2002 |